QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Mizuho

Sort by
5 items

  • This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

    Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...
    Business - MarketWatch - November 14
  • JD.com price target raised to $43 from $35 at Mizuho

    JD.com price target raised to $43 from $35 at Mizuho

    World - Yahoo News - November 13
  • Dada Nexus price target lowered to $4 from $4.50 at Mizuho

    Dada Nexus price target lowered to $4 from $4.50 at Mizuho

    World - Yahoo News - November 13
  • Bilibili price target raised to $21 from $17 at Mizuho

    Bilibili price target raised to $21 from $17 at Mizuho

    World - Yahoo News - November 13
  • Trip.com price target raised to $78 from $65 at Mizuho

    Trip.com price target raised to $78 from $65 at Mizuho

    World - Yahoo News - November 13
  • 1
  Follow topic
© 2024 QuikReader - About - Terms - Privacy